Skip to main content

AY-27 RAT BLADDER TUMOR CELL LINE

Catalog No.
C005B-315621
Manufacturer No.
SCC254
Manufacturer Name
Sigma-Aldrich
Quantity
1
Unit of Measure
EA

General description Bladder cancer is one of the top ten most common malignancies worldwide, and no cure is available for metastatic stages of the disease (1). Bladder cancer generally arises from the inner epithelial layer (urothelium) (1).

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

General description

Bladder cancer is one of the top ten most common malignancies worldwide, and no cure is available for metastatic stages of the disease (1). Bladder cancer generally arises from the inner epithelial layer (urothelium) (1). A suitable bladder tumor model that recapitulates human disease both histologically and behaviorally is essential for evaluating new therapeutic agents and modes of treatment. Rat models more closely parallel human bladder carcinoma than mouse models regarding configuration and progress of the disease (2).

The AY-27 rat bladder tumor cell line is a urothelium-derived transitional cell carcinoma (3) and is the most widely used animal model for bladder cancer. AY-27 cells are tumorigenic and are characterized by low adenylate cyclase activity (4), lack of FasL expression, and positive staining for the urothelial marker cytokeratin-7.5 Tumors derived from AY-27 cells demonstrate orthotopic growth, allowing exposure to anti-tumor drugs in a natural environment (5). The high reproducibility and clinical relevance of the AY-27 tumor model has contributed greatly to the understanding of bladder cancer and evaluation of potential treatments.

References:
1. Sanli O et al. (2017) Bladder cancer. Nat Rev Dis Primers 3: 17022.
2. Oyasu R (1995) Epithelial tumors of the lower urinary tract in humans and rodents. Food Chem Toxicol. 33(9): 747-755.
3. Cohen SM et al. (1981) Transplantation and cell culture of rat urinary bladder carcinoma. Invest Urol. 19(3): 136-141.
4. Chlapowski FJ, Nemecek GM (1985) Aberrant cyclic adenosine 3′:5′-monophosphate metabolism in cultures of tumorigenic rat urothelium. Cancer Res. 45(1): 122-127.
5. Xiao Z et al. (1999) Characterization of a novel transplantable orthotopic rat bladder transitional cell tumor model. Br J Cancer 81(4): 638-646.

Source: The AY-27 cell line was established from a primary bladder tumor induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) treatment of Fischer F344 rats (2).

Application

This product is intended for sale and sold solely to academic institutions for internal academic research use per the terms of the “Academic Use Agreement” as detailed in the product documentation. For information regarding any other use, please contact licensing@emdmillipore.com.

Quality

  • Each vial contains >=1X106 viable cells.
  • Cells are tested negative for infectious diseases by a Mouse/Rat Comprehensive CLEAR panel by Charles River Animal Diagnostic Services.
  • Cells are verified to be of rat origin and negative for inter-species contamination from mouse, chinese hamster, Golden Syrian hamster, human and non-human primate (NHP) as assessed by a Contamination CLEAR panel by Charles River Animal Diagnostic Services.
  • Cells are negative for mycoplasma contamination.

Storage and Stability

Store in liquid nitrogen. The cells can be cultured for at least 10 passages after initial thawing without significantly affecting the cell marker expression and functionality.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

UPC:
42295125
Condition:
New
HazmatClass:
No
MPN:
SCC254

Cenmed Satisfaction Guarantee
Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

Testimonial
"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."

LAB DIRECTOR

Testimonial
"We utilized Cenmed's capabilities for a variety of projects around the world. They are a valued partner and supplier."

PHARMACEUTICAL SUPPLY CHAIN LEADER

Testimonial
"The reps are very good at finding products for customers in this period of supply chain issues."

SCOTT BEHMAN

Testimonial
"Your customer service has been excellent and makes me excited about purchasing with Cenmed in the future!!"

PROCUREMENT + BILLING COORDINATOR AT PHARMA.